%0 Journal Article
%T SUMO化通路及其抑制剂研究概述<br> Overview of the Sumo-Chemical Pathway and Its Inhibitors
%A 于祥旭
%A 陆美玲
%J Bioprocess
%P 20-25
%@ 2164-5582
%D 2022
%I Hans Publishing
%R 10.12677/BP.2022.121003
%X <div style=\"text-align:justify;\">
	<span style=\"font-size:14px;\">SUMO化(SUMOylation)是一种可逆的翻译后修饰，是一种重要的分子调控机制，参与调控DNA损伤修复、免疫反应、癌变、细胞周期进程和细胞凋亡。现在已经发现了四种SUMO亚型，分别是SUMO1、SUMO2/3和SUMO4。小泛素样修饰物(SUMO)通路在所有真核生物中都是保守的，在基因表达调控、细胞信号转导和基因组完整性的维持中起着关键作用。SUMO的催化循环包括成熟、活化、偶联、连接和去修饰。SUMO系统的失调与许多疾病有关，特别是癌症。SUMO化修饰广泛参与肿瘤的癌变、DNA损伤反应、癌细胞的增殖、转移和凋亡。SUMO可以作为癌症的潜在治疗靶点。为了更好地理解SUMO在人类疾病中的作用，我们简要概述了SUMO系统的基本概念，并总结了SUMO蛋白在癌细胞中的作用以及最近关于这一通路的抑制剂研究进展。<br />
SUMOylation, a reversible
modification after translation, is a kind of molecular regulation mechanism
which participated in the regulation of DNA damage repair, immune reaction, process
of cancerous cell cycle and cell apoptosis. Four subtypes of SUMO have been found,
including SUMO1 SUMO2/3 and SUMO4. The small ubiquitin like modification (SUMO)
pathway is conserved in all eukaryotes and plays a key role in gene expression
regulation of cellular signal transduction and maintenance of genomic
integrity. Dysregulation of the SUMO catalytic cycle has been associated with
many diseases, especially cancer. In order to better understand the role of
SUMO in human disease, we briefly outline the basic concepts of the SUMO system
and summarize the role of SUMO proteins in cancer cells and the advances in
inhibitors of this pathway.</span><span style=\"font-size:14px;\"></span> 
</div>
%K SUMO，SUMO化，蛋白修饰，抑制剂，癌症<br> SUMO
%K SUMOylation
%K Protein Modification
%K Inhibitor
%K Cancer
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=49531